Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 1.571E-08 | 2.528E-05 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0050896; response to stimulus | GO:0070542; response to fatty acid | 2.675E-08 | 3.641E-05 | FABP3, FFAR1, PPARG, PTGS2, TLR2 |
BP | GO:0008152; metabolic process | GO:0019372; lipoxygenase pathway | 7.112E-07 | 3.872E-04 | ALOX15, HPGD, PTGS2 |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 9.225E-07 | 4.783E-04 | FABP3, PPARA, PPARD, PPARG |
BP | GO:0009987; cellular process | GO:0071456; cellular response to hypoxia | 5.383E-06 | 1.922E-03 | LMNA, PPARD, PTGS2, TERT |
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 8.028E-06 | 2.649E-03 | FFAR4, PPARA, PPARD, PPARG |
BP | GO:0008283; cell proliferation | GO:0008285; negative regulation of cell proliferation | 8.761E-06 | 2.847E-03 | FABP3, LMNA, PPARD, PPARG, PTGS2, TERT, TLR2 |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 1.236E-05 | 3.686E-03 | PPARA, PPARG |
BP | GO:0009987; cellular process | GO:0043401; steroid hormone mediated signaling pathway | 1.304E-05 | 3.838E-03 | NR1I2, PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0032868; response to insulin | 1.699E-05 | 4.742E-03 | FABP3, PPARA, PPARG, TLR2 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 4.189E-05 | 8.378E-04 | ALOX15; PTGS2; PTGS1 |
hsa03320 | PPAR signaling pathway_Homo sapiens_hsa03320 | 6.963E-13 | 4.178E-11 | FABP2; FABP3; FABP4; FABP5; PPARG; PPARA; PPARD |
hsa04726 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.436E-04 | 3.654E-03 | ALOX15; PTGS2; PTGS1 |
hsa04923 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.883E-07 | 1.165E-05 | FABP4; PTGS2; TSHR; PTGS1 |
hsa05140 | Leishmaniasis_Homo sapiens_hsa05140 | 2.895E-03 | 3.474E-02 | PTGS2; TLR2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | ABCB1 |
C00-D49: Neoplasms | Myelodysplastic syndrome | D46 | TLR2 |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | FAAH; PTGS2; PTGS1 |
C00-D49: Neoplasms | Multiple myeloma | C90 | TERT |
C00-D49: Neoplasms | Liver cancer | C22 | TERT |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | PTGS1 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
C00-D49: Neoplasms | Tumors | C00-D48 | TERT |
C00-D49: Neoplasms | Solid tumours | C00-D48 | ABCB1; TLR2 |
C00-D49: Neoplasms | Prostate cancer | C61 | TLR2; TERT |